- Home
- RMTI vs PULM Comparison
RMTI vs PULM Comparison
Compare RMTI & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMTI
- PULM
- Stock Information
- Founded
- RMTI 1994
- PULM 2003
- Country
- RMTI United States
- PULM United States
- Employees
- RMTI N/A
- PULM N/A
- Industry
- RMTI Biotechnology: Pharmaceutical Preparations
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- RMTI Health Care
- PULM Health Care
- Exchange
- RMTI Nasdaq
- PULM Nasdaq
- Market Cap
- RMTI 32.5M
- PULM 33.2M
- IPO Year
- RMTI 1998
- PULM N/A
- Fundamental
- Price
- RMTI $1.00
- PULM $6.50
- Analyst Decision
- RMTI Strong Buy
- PULM
- Analyst Count
- RMTI 2
- PULM 0
- Target Price
- RMTI $4.00
- PULM N/A
- AVG Volume (30 Days)
- RMTI 245.8K
- PULM 60.4K
- Earning Date
- RMTI 08-07-2025
- PULM 08-12-2025
- Dividend Yield
- RMTI N/A
- PULM N/A
- EPS Growth
- RMTI N/A
- PULM N/A
- EPS
- RMTI N/A
- PULM N/A
- Revenue
- RMTI $97,727,000.00
- PULM $1,921,000.00
- Revenue This Year
- RMTI N/A
- PULM N/A
- Revenue Next Year
- RMTI $11.16
- PULM $134.88
- P/E Ratio
- RMTI N/A
- PULM N/A
- Revenue Growth
- RMTI 12.82
- PULM N/A
- 52 Week Low
- RMTI $0.78
- PULM $1.78
- 52 Week High
- RMTI $5.15
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- RMTI 56.72
- PULM 39.79
- Support Level
- RMTI $0.80
- PULM $6.26
- Resistance Level
- RMTI $0.87
- PULM $6.96
- Average True Range (ATR)
- RMTI 0.06
- PULM 0.87
- MACD
- RMTI 0.01
- PULM -0.12
- Stochastic Oscillator
- RMTI 94.81
- PULM 40.16
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).